To begin to understand the regulation of FoxM1 by p53 in cancer cells, we first examined the effects of MDM2 inhibitor Nutlin-3 on the expression of p53 and FoxM1 proteins in several cancer cell lines with either wild-type or mutant TP53 (Figure 1A). This evidence concerns the gene TP53 and cancer.